Biocryst Pharmaceuticals buy Evercore ISI
Start price
13.01.25
/
50%
€7.73
Target price
13.01.26
€11.76
Performance (%)
-21.43%
Price
17.12.25
€6.07
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -21.43%. This prediction currently runs until 13.01.26. The prediction end date can be changed by Evercore_ISI at any time. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -7.413% | -7.413% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Evercore ISI from $10.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.67
20.04.23
20.04.23
€9.11
20.04.24
20.04.24
-38.50%
21.04.24
21.04.24
